Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hagan, JJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hatcher, JP; Jones, DNC; Rogers, DC; Hatcher, PD; Reavill, C; Hagan, JJ; Hunter, AJ
      Development of SHIRPA to characterise the phenotype of gene-targeted mice

      BEHAVIOURAL BRAIN RESEARCH
    2. Roberts, C; Allen, L; Langmead, CJ; Hagan, JJ; Middlemiss, DN; Price, GW
      The effect of SB-269970, a 5-HT7 receptor antagonist, on 5-HT release fromserotonergic terminals and cell bodies

      BRITISH JOURNAL OF PHARMACOLOGY
    3. Rogers, DC; Hagan, JJ
      5-HT6 receptor antagonists enhance retention of a water maze task in the rat

      PSYCHOPHARMACOLOGY
    4. Cilia, J; Reavill, C; Hagan, JJ; Jones, DNC
      Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats

      PSYCHOPHARMACOLOGY
    5. Heidbreder, CA; Foxton, R; Cilia, J; Hughes, ZA; Shah, AJ; Atkins, A; Hunter, AJ; Hagan, JJ; Jones, DNC
      Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation

      PSYCHOPHARMACOLOGY
    6. Gartlon, J; Parker, F; Harrison, DC; Douglas, SA; Ashmeade, TE; Riley, GJ; Hughes, ZA; Taylor, SG; Munton, RP; Hagan, JJ; Hunter, JA; Jones, DNC
      Central effects of urotensin-II following ICV administration in rats

      PSYCHOPHARMACOLOGY
    7. Cilia, J; Piper, DC; Upton, N; Hagan, JJ
      Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule

      PSYCHOPHARMACOLOGY
    8. Jones, DNC; Gartlon, J; Parker, F; Taylor, SG; Routledge, C; Hemmati, P; Munton, RP; Ashmeade, TE; Hatcher, JP; Johns, A; Porter, RA; Hagan, JJ; Hunter, AJ; Upton, N
      Effects of centrally administered orexin-1 and orexinA: a role for orexin-1 receptors in orexin-B-induced hyperactivity

      PSYCHOPHARMACOLOGY
    9. Bull, E; Reavill, C; Hagan, JJ; Overend, P; Jones, DNC
      Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test

      BEHAVIOURAL BRAIN RESEARCH
    10. Roberts, C; Hatcher, P; Hagan, JJ; Austin, NE; Jeffrey, P; Wyman, P; Gaster, LM; Routledge, C; Middlemiss, DN
      The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, onin vivo extracellular 5-HT levels in the freely-moving guinea-pig

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    11. Reavill, C; Taylor, SG; Wood, MD; Ashmeade, T; Austin, NE; Avenell, KY; Boyfield, I; Branch, CL; Cilia, J; Coldwell, MC; Hadley, MS; Hunter, AJ; Jeffrey, P; Jewitt, F; Johnson, CN; Jones, DNC; Medhurst, AD; Middlemiss, DN; Nash, DJ; Riley, GJ; Routledge, C; Stemp, G; Thewlis, KM; Trail, B; Vong, AKK; Hagan, JJ
      Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    12. Ashby, CR; Minabe, Y; Stemp, G; Hagan, JJ; Middlemiss, DN
      Acute and chronic administration of the selective D-3 receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Stemp, G; Ashmeade, T; Branch, CL; Hadley, MS; Hunter, AJ; Johnson, CN; Nash, DJ; Thewlis, KM; Vong, AKK; Austin, NE; Jeffrey, P; Avenell, KY; Boyfield, I; Hagan, JJ; Middlemiss, DN; Reavill, C; Riley, GJ; Routledge, C; Wood, M
      Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Lovell, PJ; Bromidge, SM; Dabbs, S; Duckworth, DM; Forbes, IT; Jennings, AJ; King, FD; Middlemiss, DN; Rahman, SK; Saunders, DV; Collin, LL; Hagan, JJ; Riley, GJ; Thomas, DR
      A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

      JOURNAL OF MEDICINAL CHEMISTRY
    15. Hagan, JJ; Price, GW; Jeffrey, P; Deeks, NJ; Stean, T; Piper, D; Smith, MI; Upton, N; Medhurst, AD; Middlemiss, DN; Riley, GJ; Lovell, PJ; Bromidge, SM; Thomas, DR
      Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist

      BRITISH JOURNAL OF PHARMACOLOGY
    16. Thomas, DR; Atkinson, PJ; Ho, M; Bromidge, SM; Lovell, PJ; Villani, AJ; Hagan, JJ; Middlemiss, DN; Price, GW
      [H-3]-SB-269970 - A selective antagonist radioligand for 5-HT7 receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    17. Rogers, DC; Costall, B; Domeney, AM; Gerrard, PA; Greener, M; Kelly, ME; Hagan, JJ; Hunter, AJ
      Anxiolytic profile of ropinirole in the rat, mouse and common marmoset

      PSYCHOPHARMACOLOGY
    18. Rogers, DC; Jones, DNC; Nelson, PR; Jones, CM; Quilter, CA; Robinson, TL; Hagan, JJ
      Use of SHIRPA and discriminant analysis to characterise marked differencesin the behavioural phenotype of six inbred mouse strains

      BEHAVIOURAL BRAIN RESEARCH
    19. Hagan, JJ; Leslie, RA; Patel, S; Evans, ML; Wattam, TA; Holmes, S; Benham, CD; Taylor, SG; Routledge, C; Hemmati, P; Munton, RP; Ashmeade, TE; Shah, AS; Hatcher, JP; Hatcher, PD; Jones, DNC; Smith, MI; Piper, DC; Hunter, AJ; Porter, RA; Upton, N
      Orexin A activates locus coeruleus cell firing and increases arousal in the rat

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    20. Jones, DNC; Kortekaas, R; Hatcher, PD; Middlemiss, DN; White, A; Hagan, JJ
      Influence of peptide CRF receptor antagonists upon the behavioural effectsof human rat CRF

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Cilia, J; Piper, DC; Upton, N; Hagan, JJ
      A comparison of rectal and subcutaneous body temperature measurement in the common marmoset

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    22. GASTER LM; BLANEY FE; DAVIES S; DUCKWORTH DM; HAM P; JENKINS S; JENNINGS AJ; JOINER GF; KING FD; MULHOLLAND KR; WYMAN PA; HAGAN JJ; HATCHER J; JONES BJ; MIDDLEMISS DN; PRICE GW; RILEY G; ROBERTS C; ROUTLEDGE C; SELKIRK J; SLADE PD
      THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO

      Journal of medicinal chemistry
    23. FORBES IT; DABBS S; DUCKWORTH DM; JENNINGS AJ; KING FD; LOVELL PJ; BROWN AM; COLLIN L; HAGAN JJ; MIDDLEMISS DN; RILEY GJ; THOMAS DR; UPTON N
      (4-METHYL-PIPERIDIN-1-YL)PROPYL]BENZENESULFONAMIDE - THE FIRST SELECTIVE 5-HT7 RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    24. ROGERS DC; JONES DNC; SLADE PD; HARPER AJ; HUNTER AJ; HAGAN JJ
      DETAILED BEHAVIORAL-PHENOTYPE CHARACTERIZATION OF APOE KNOCKOUT MICE

      British Journal of Pharmacology
    25. JONES DNC; BOYD DF; CILIA J; WHITE A; HAGAN JJ
      DIFFERENTIAL REINFORCEMENT OF LOW RESPONSE RATE (DRL-72S) SCHEDULE - EFFECTS OF ANTIDEPRESSANTS

      British Journal of Pharmacology
    26. Hatcher, JP; Hagan, JJ
      The effects of dopamine D-3/D-2 receptor agonists on intracranial self stimulation in the rat

      PSYCHOPHARMACOLOGY
    27. HATCHER JP; LOUDON JM; HAGAN JJ; CLARK MSG
      SABCOMELINE (8B-202026), A FUNCTIONALLY SELECTIVE M-1 RECEPTOR PARTIAL AGONIST, REVERSES DELAY-INDUCED DEFICITS IN THE T-MAZE

      Psychopharmacology
    28. JONES DNC; KORTEKAAS R; SLADE PD; MIDDLEMISS DN; HAGAN JJ
      THE BEHAVIORAL-EFFECTS OF CORTICOTROPIN-RELEASING FACTOR-RELATED PEPTIDES IN RATS

      Psychopharmacology
    29. HATCHER JP; BELL DJ; REED TJ; HAGAN JJ
      CHRONIC MILD STRESS-INDUCED REDUCTIONS IN SACCHARIN INTAKE DEPEND UPON FEEDING STATUS

      JOURNAL OF PSYCHOPHARMACOLOGY
    30. HAGAN JJ; SLADE PD; GASTER L; JEFFREY P; HATCHER JP; MIDDLEMISS DN
      STIMULATION OF 5-HT1B RECEPTORS CAUSES HYPOTHERMIA IN THE GUINEA-PIG

      European journal of pharmacology
    31. JONES DNC; KORTEKAAS R; SLADE PD; HAGAN JJ
      COMPARISON OF BEHAVIORAL-EFFECTS OF CORTICOTROPIN-RELEASING FACTOR AND THE NOVEL NEUROPEPTIDE, UROCORTIN

      British Journal of Pharmacology
    32. HAGAN JJ; MIDDLEMISS DN; SHARPE PC; POSTE GH
      IMPROVED THERAPIES FOR PARKINSONS-DISEASE - LIFE BEYOND DOPAMINE D2 D3 RECEPTOR AGONISTS - REPLY/

      Trends in pharmacological sciences
    33. HAGAN JJ; MIDDLEMISS DN; SHARPE PC; POSTE GH
      PARKINSONS-DISEASE - PROSPECTS FOR IMPROVED DRUG-THERAPY

      Trends in pharmacological sciences
    34. HAGAN JJ; HATCHER JP
      REVISED CMS MODEL

      Psychopharmacology
    35. LLOYD PS; SLADE PD; HATCHER JP; HAGAN JJ
      A COMPUTER-CONTROLLED APPARATUS FOR MEASURING AND ANALYZING MYOCLONICJERK ACTIVITY IN GUINEA-PIGS

      Journal of neuroscience methods
    36. BOYFIELD I; BROWN TH; COLDWELL MC; COOPER DG; HADLEY MS; HAGAN JJ; HEALY MA; JOHNS A; KING RJ; MIDDLEMISS DN; NASH DJ; RILEY GJ; SCOTT EE; SMITH SA; STEMP G
      DESIGN AND SYNTHESIS OF 2-NAPHTHOATE ESTERS AS SELECTIVE DOPAMINE D-4ANTAGONISTS

      Journal of medicinal chemistry
    37. REAVILL C; HATCHER JP; ZETTERSTROM TSC; LEWIS AV; SANGER GJ; HAGAN JJ; MCKAY S
      5-HT4 RECEPTOR ANTAGONISM DOES NOT AFFECT DOPAMINE-MEDIATED BEHAVIORAL-EFFECTS IN THE RAT

      British Journal of Pharmacology
    38. HATCHER JP; BOYLAND P; HAGAN JJ
      THE 5-HT3 RECEPTOR ANTAGONISTS, GRANISETRON AND ONDANSETRON, DO NOT AFFECT COCAINE-INDUCED SHIFTS IN INTRACRANIAL SELF-STIMULATION THRESHOLDS

      JOURNAL OF PSYCHOPHARMACOLOGY
    39. HATCHER JP; SLADE PD; ROBERTS C; HAGAN JJ
      5-HT1D RECEPTORS MEDIATE SKF 99101H-INDUCED HYPOTHERMIA IN THE GUINEA-PIG

      JOURNAL OF PSYCHOPHARMACOLOGY
    40. HAGAN JJ; HATCHER JP; SLADE PD
      THE ROLE OF 5-HT1D AND 5-HT1A RECEPTORS IN MEDIATING 5-HYDROXYTRYPTOPHAN INDUCED MYOCLONIC JERKS IN GUINEA-PIGS

      European journal of pharmacology
    41. ROMPRE PP; INJOYAN R; HAGAN JJ
      EFFECTS OF GRANISETRON, A 5-HT3 RECEPTOR ANTAGONIST, ON MORPHINE-INDUCED POTENTIATION OF BRAIN-STIMULATION REWARD

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 00:32:07